Interleukin-4 (IL-4) as a Marker of Atherosclerosis
NCT00256035
·
clinicaltrials.gov ↗
NA
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Conditions
Atherosclerosis
Ischemic Heart Disease
Interventions
PROCEDURE:
Measuring IL-4 levels
Sponsor
Melbourne Health
Collaborators
[object Object]